Assessing cognitive effects of anticholinergic medications in patients with coronary artery disease.
about
Lipid Peroxidation Markers in Coronary Artery Disease Patients with Possible Vascular Mild Cognitive Impairment.Different methods, different results--how do available methods link a patient's anticholinergic load with adverse outcomes?Comparison of anticholinergic risk scales and associations with adverse health outcomes in older people.The Impact of Medication Anticholinergic Burden on Cognitive Performance in People With Schizophrenia.Subcortical hyperintensities in the cholinergic system are associated with improvements in executive function in older adults with coronary artery disease undergoing cardiac rehabilitation.Anticholinergic Toxicity Secondary to Overuse of Topricin Cream, a Homeopathic Medication.Cognitive function in patients with coronary artery disease: A literature review
P2860
Q33787909-6185F3F4-4ACA-4BE6-943C-42B2B7296049Q38583153-74921640-4F8B-49E3-A827-ED958707189CQ41568753-871BECE7-C320-4668-A942-BC155CDB9642Q47133877-45B49A36-3822-4CFD-B849-C33B7D0083A6Q47379319-845E7B38-DEC7-41A3-8B6E-16A9E3310E7BQ55316987-513A4564-DB39-4C4D-A367-E0D29719E9B6Q58692465-123C9026-7565-4838-AAD8-1F8AAAC1C748
P2860
Assessing cognitive effects of anticholinergic medications in patients with coronary artery disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Assessing cognitive effects of ...... with coronary artery disease.
@en
type
label
Assessing cognitive effects of ...... with coronary artery disease.
@en
prefLabel
Assessing cognitive effects of ...... with coronary artery disease.
@en
P2093
P1433
P1476
Assessing cognitive effects of ...... with coronary artery disease.
@en
P2093
Jordana O'Regan
Mahwesh Saleem
Nathan Herrmann
Yael Schwartz
P356
10.1016/J.PSYM.2013.04.004
P577
2013-08-30T00:00:00Z